Acquisitions (Details Narrative) - USD ($) |
12 Months Ended | ||
|---|---|---|---|
Mar. 05, 2019 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
| Gain on bargain purchase | $ 250,000 | ||
| Impairment of intangible asset | 250,000 | ||
| Jellico Community Hospital and Careplus Center [Member] | |||
| Purchase price paid | $ 658,537 | ||
| Acquisition cots | 908,537 | ||
| Diligence, legal and other costs | 250,000 | ||
| Fair value of the assets acquired, net of the liabilities assumed | 908,537 | ||
| Gain on bargain purchase | $ 250,000 | ||
| Impairment of intangible asset | $ 250,000 | ||
| X | ||||||||||
- Definition Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition. No definition available.
|
| X | ||||||||||
- Definition This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition In a business combination in which the amount of net identifiable assets acquired and liabilities assumed exceeds the aggregate consideration transferred or to be transferred (as defined), this element represents the amount of gain recognized by the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|